Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;19(6):1705-1723.
doi: 10.1007/s13311-022-01251-6. Epub 2022 May 31.

Updates in IDH-Wildtype Glioblastoma

Jawad M Melhem  1 , Jay Detsky  2 , Mary Jane Lim-Fat #  1 , James R Perry #  3
Affiliations
Review

Updates in IDH-Wildtype Glioblastoma

Jawad M Melhem et al. Neurotherapeutics. 2022 Oct.

Abstract

Glioblastoma is the most aggressive primary brain tumor with a poor prognosis. The 2021 WHO CNS5 classification has further stressed the importance of molecular signatures in diagnosis although therapeutic breakthroughs are still lacking. In this review article, updates on the current and novel therapies in IDH-wildtype GBM will be discussed.

Keywords: Clinical trials; Glioblastoma; IDH-wildtype; Precision medicine; Targeted therapy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A 70-year-old woman who presented with headache and behavioral changes and was found to have an IDH-wildtype GBM over the left frontal region causing minimal mass effect. Contrast-enhanced T1 image shows a large necrotic mass over the left frontal region with irregular thick rind (A). Elevated CBV on MR perfusion correlates to areas of enhancement (B). Compared to DWI map (C), cellular heterogeneity is evident within the tumor fields as more hypercellular areas demonstrates higher signal drop on ADC map (D)
Fig. 2
Fig. 2
Proposed molecular testing algorithm for HGG. *Consider testing in young adults. Abbreviations: HGG, high-grade gliomas; IDH, isocitrate dehydrogenase; FISH, fluorescence in situ hybridization; SNP, single nucleotide polymorphism; WHO, World Health Organization; DMG, diffuse midline glioma; EGFR, epidermal growth factor receptor; RNA, ribonucleic acid; EZHIP, EZH Inhibitory Protein; MMR, mismatch repair; cMMRD, constitutional mismatch repair deficiency; BRAF, B-Raf; MYCN, N-myc proto oncogene; RTK, receptor tyrosine kinase; NTRK, neurotrophic tyrosine receptor kinase; TERT, telomerase reverse transcriptase
See this image and copyright information in PMC

References

    1. Canoll P, Goldman JE. The interface between glial progenitors and gliomas. Acta Neuropathol. 2008;116(5):465–477. doi: 10.1007/s00401-008-0432-9. - DOI - PMC - PubMed
    1. Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature. 2018;560(7717):243–247. doi: 10.1038/s41586-018-0389-3. - DOI - PubMed
    1. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–1251. doi: 10.1093/neuonc/noab106. - DOI - PMC - PubMed
    1. Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol. 2020;22(Supplement_1):iv1–iv96. doi: 10.1093/neuonc/noaa200. - DOI - PMC - PubMed
    1. Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014. JAMA Oncol. 2018;4(9):1254–1262. doi: 10.1001/jamaoncol.2018.1789. - DOI - PMC - PubMed

Substances